Funding

Korsana Biosciences

United States · Biotech · Healthtech

Develops therapies for neurodegenerative diseases.

Visit korsana.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$175MFairmount — Role not disclosedForesite Capital — Role not disclosedJanus Henderson Investors — Role not disclosedJ.P. Morgan Life Sciences Private Capital — Role not disclosedSanofi Ventures — Role not disclosedTCGX — Role not disclosedVenrock Healthcare Capital Partners — Role not disclosedWellington Management — Role not disclosed

Investors

FairmountSeries AForesite CapitalSeries AJanus Henderson InvestorsSeries AJ.P. Morgan Life Sciences Private CapitalSeries ASanofi VenturesSeries ATCGXSeries AVenrock Healthcare Capital PartnersSeries AWellington ManagementSeries A

Coverage

Feb 18, 2026Korsana Biosciences · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesprojectstartups.com ↗